Clinical trial
Desvenlafaxine for the Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen: a Randomized, Double-blind, Placebo-controlled Study
NCT02819921 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Desvenlafaxine for the Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen: a Randomized, Double-blind, Placebo-controlled Study
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- November 10, 2017
- Completion date
- June 15, 2019
- Enrollment
- 59 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.